1. Clostridium septicum myonecrosis following chemotherapy

   • Omali Pitiyarachchi
   • Nicholas Viiala

   Images in Hematology 11 March 2022 Pages: 609 - 610

   

2. Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation

   • Takafumi Tsushima
   • Toshiki Terao
   • Kosei Matsue

   Rapid Communication 15 April 2022 Pages: 611 - 615

   

3. Philadelphia chromosome-negative myeloproliferative neoplasms: clinical aspects and treatment options

   • Akihiko Gotoh

   Progress in Hematology 10 April 2022 Pages: 616 - 618

4. Improving allogeneic stem cell transplantation in myelofibrosis

   • Nico Gagelmann
   • Nicolaus Kröger

   Progress in Hematology 13 April 2022 Pages: 619 - 625

   

5. Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives

   • Giuseppe G. Loscocco
   • Alessandro M. Vannucchi

   Progress in Hematology 29 March 2022 Pages: 626 - 644

6. Novel treatments for myelofibrosis: beyond JAK inhibitors

   • Douglas Tremblay
   • Ruben Mesa

   Progress in Hematology 19 February 2022 Pages: 645 - 658

   

7. Treatment options and pregnancy management for patients with PV and ET

   • Yoko Edahiro

   Progress in Hematology 08 April 2022 Pages: 659 - 671

   

8. Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development

   • Tsukasa Osaki
   • Masayoshi Souri
   • Akitada Ichinose

   Original Article 10 February 2022 Pages: 672 - 685

   

9. UBC9 inhibits myeloid differentiation in collaboration with AML1-MTG8

   • Tomofusa Fukuyama
   • Toshio Kitamura
   • Tomoko Kozu

   Original Article 12 February 2022 Pages: 686 - 693

   

10. A phase II randomized study evaluating azacitidine versus conventional care regimens in newly diagnosed elderly Japanese patients with unfavorable acute myeloid leukemia

    • Hiroatsu Iida
    • Kazunori Imada
    • the Study Group

    Original Article 24 February 2022 Pages: 694 - 703

    

11. NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan

    • Wen-Li Hwang
    • Tsung-Chih Chen
    • Jih-Luh Tang

    Original Article 25 February 2022 Pages: 704 - 712

    

12. A retrospective single-center analysis of G-CSF-mobilized donor lymphocyte infusion in hematologic malignancies after unmanipulated allogenic PBSCT

    • Ning Lu
    • Ji Lin
    • Xiao-Ning Gao

    Original Article 06 February 2022 Pages: 713 - 727

    

13. Antibody response to COVID-19 vaccination in patients with lymphoma

    • Kentaro Narita
    • So Nakaji
    • Kosei Matsue

    Original Article 21 February 2022 Pages: 728 - 736

    

14. Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma

    • Toshiki Terao
    • Takeshi Yamashita
    • Kosei Matsue

    Original Article 21 February 2022 Pages: 737 - 747

    

15. Emergence of clone with PHF6 nonsense mutation in chronic myelomonocytic leukemia at relapse after allogeneic HCT

    • Yu Akahoshi
    • Hideki Nakasone
    • Yoshinobu Kanda

    Case Report 06 January 2022 Pages: 748 - 752

    

16. Relationship between donor-specific HPA-15 antibodies and poor graft function in HPA-15 mismatched cord blood transplantation

    • Masato Yasumi
    • Takafumi Yokota
    • Takahiro Karasuno

    Case Report 13 January 2022 Pages: 753 - 758